114 related articles for article (PubMed ID: 1919650)
1. Radioimmunoassay of glioma associated antigen in CSF and its usefulness for the diagnosis and monitoring of human glioma.
Fumagalli R; Paoletti P
J Neurooncol; 1991 Aug; 11(1):81. PubMed ID: 1919650
[No Abstract] [Full Text] [Related]
2. Radioimmunoassay of glioma-associated antigen in cerebrospinal fluid and its usefulness for the diagnosis and monitoring of human glioma.
Yoshida J; Yamamoto R; Wakabayashi T; Nagata M; Seo H
J Neurooncol; 1990 Feb; 8(1):23-31. PubMed ID: 2319287
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid sterols in the evaluation of patients with gliomas.
Ransohoff J; Weiss J
Natl Cancer Inst Monogr; 1977 Dec; 46():119-24. PubMed ID: 613222
[TBL] [Abstract][Full Text] [Related]
4. Desmosterol: a biochemical marker of glioma growth.
Paoletti P; Fumagalli R; Weiss JF; Pezzotta S
Surg Neurol; 1977 Dec; 8(6):399-405. PubMed ID: 594877
[No Abstract] [Full Text] [Related]
5. HMFG1 antigen: a new marker for carcinomatous meningitis.
Moseley RP; Oge K; Shafqat S; Moseley CM; Sullivan NM; Badley RA; Burchell J; Taylor-Papadimitriou J; Coakham HB
Int J Cancer; 1989 Sep; 44(3):440-4. PubMed ID: 2777410
[TBL] [Abstract][Full Text] [Related]
6. Detection of intracranial tumours with special reference to immunodiagnosis.
Bagshawe KD; Harland S
Proc R Soc Med; 1976 Jan; 69(1):51-3. PubMed ID: 945577
[No Abstract] [Full Text] [Related]
7. Characterization of neuroectodermal antigen by a monoclonal antibody and its application in CSF diagnosis of human glioma.
Wakabayashi T; Yoshida J; Seo H; Kazo K; Murata Y; Matsui N; Kageyama N
J Neurosurg; 1988 Mar; 68(3):449-55. PubMed ID: 3343615
[TBL] [Abstract][Full Text] [Related]
8. Behavior of prostatic specific antigen (PSA) in spinal fluid: its correlation with serum levels.
Morote J; Ruibal A; Boada M
Int J Biol Markers; 1986; 1(2):109-10. PubMed ID: 2448396
[No Abstract] [Full Text] [Related]
9. Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas.
Shen F; Zhang Y; Yao Y; Hua W; Zhang HS; Wu JS; Zhong P; Zhou LF
Neurosurg Rev; 2014 Jul; 37(3):367-80; discussion 380. PubMed ID: 24781189
[TBL] [Abstract][Full Text] [Related]
10. Faliure to demonstrate desmosterol in spinal fluid of brain tumor patients.
Marton LJ; Gordan GS; Barker M; Wilson CB; Lubich W
Arch Neurol; 1973 Feb; 28(2):137-8. PubMed ID: 4345665
[No Abstract] [Full Text] [Related]
11. Biochemical markers of central nervous system tumors measured in cerebrospinal fluid and their potential use in diagnosis and patient management: a review.
Seidenfeld J; Marton LJ
J Natl Cancer Inst; 1979 Oct; 63(4):919-31. PubMed ID: 384010
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Value of CYFRA 21-1 in the Cerebrospinal Fluid for Leptomeningeal Metastasis.
Zhang Z; Tian C; Shi Q; Hao J; Zhao N; Liu Z
Dis Markers; 2017; 2017():2467870. PubMed ID: 28298807
[TBL] [Abstract][Full Text] [Related]
13. Selected ion monitoring technique for the evaluation of sterols in cerebrospinal fluid: a new approach to desmosterol test for central nervous system tumors.
Bernini F; Sangiovanni G; Pezzotta S; Galli G; Fumagalli R; Paoletti P
J Neurooncol; 1986; 4(1):31-5. PubMed ID: 3746383
[TBL] [Abstract][Full Text] [Related]
14. Tissue polypeptide antigen activity in cerebrospinal fluid: a marker of central nervous system metastases of breast cancer.
Bach F; Soletormos G; Dombernowsky P
J Natl Cancer Inst; 1991 Jun; 83(11):779-84. PubMed ID: 2041052
[TBL] [Abstract][Full Text] [Related]
15. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.
Shi R; Wang PY; Li XY; Chen JX; Li Y; Zhang XZ; Zhang CG; Jiang T; Li WB; Ding W; Cheng SJ
Oncotarget; 2015 Sep; 6(29):26971-81. PubMed ID: 26284486
[TBL] [Abstract][Full Text] [Related]
16. Desmosterol in CSF.
Paoletti P
Neurology; 1981 May; 31(5):639-40. PubMed ID: 7194986
[No Abstract] [Full Text] [Related]
17. Sialyllactotetraosylceramide, a ganglioside marker for human malignant gliomas.
Fredman P; von Holst H; Collins VP; Granholm L; Svennerholm L
J Neurochem; 1988 Mar; 50(3):912-9. PubMed ID: 3339365
[TBL] [Abstract][Full Text] [Related]
18. Extracellular miRNA-21 as a novel biomarker in glioma: Evidence from meta-analysis, clinical validation and experimental investigations.
Qu K; Lin T; Pang Q; Liu T; Wang Z; Tai M; Meng F; Zhang J; Wan Y; Mao P; Dong X; Liu C; Niu W; Dong S
Oncotarget; 2016 Jun; 7(23):33994-4010. PubMed ID: 27166186
[TBL] [Abstract][Full Text] [Related]
19. Levels of astroprotein (an astrocyte-specific cerebroprotein) in cerebrospinal fluid of patients with brain tumors. An attempt at immunochemical diagnosis of gliomas.
Hayakawa T; Morimoto K; Ushio Y; Mori T; Yoshimine T; Myoga A; Mogami H
J Neurosurg; 1980 Feb; 52(2):229-33. PubMed ID: 7351563
[TBL] [Abstract][Full Text] [Related]
20. Markers of central nervous system tumors.
Birkmayer GD
Immunol Ser; 1990; 53():317-22. PubMed ID: 2100565
[No Abstract] [Full Text] [Related]
[Next] [New Search]
